Blood-Based Biomarkers Among Notable Alzheimer’s Advances
Episode Summary
Blood-based Alzheimer’s biomarkers enable earlier, less invasive diagnosis, expanding screening and research opportunities while raising concerns about accuracy, equity, access, counseling, and health system readiness for implementation.